Apoptosis
Apoptosis(凋亡)
FKBP (FK506-binding protein) is one of two major immunophilins and most of FKBP family members bind FK506 and show peptidylprolyl cis/trans isomerase (PPIase) activity. Small size FKBP family members contain only FK506-binding domain, while FKBPs with large molecular weights possess extra domains such as tetratricopeptide repeat domains, calmodulin binding and transmembrane motifs. FKBPs are involved in several biochemical processes including protein folding, receptor signaling, protein trafficking and transcription. FKBP family proteins play important functional roles in the T-cell activation, when complexed with their ligands.
FK506-binding proteins 1a and 1b (FKBP1a/1b) are immunophilin proteins that bind the immunosuppressant agent FK506 and AY 22989. FKBP12 is a ubiquitous abundant protein that acts as a receptor for FK506, binds tightly to intracellular calcium release channels and to the transforming growth factor β (TGF-β) type I receptor.
Apoptosis 相关产品(777)
- GC73943Polθ/PARP-IN-1纯度: >99.00%
Polθ/PARP-IN-1(化合物25d)是一种有效的双DNA聚合酶θ (Polθ)和PARP抑制剂,IC50值分别为45.6和5.4 nM。
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC73697 | STM3006 | 2499664-52-5 | >97.00% | |
STM3006是一种高效、选择性和口服活性的METTL3抑制剂(IC50:5nM)。 | ||||
| GC73740 | DCZ5418 | 2883709-99-5 | >99.00% | |
DCZ5418是TRIP13的抑制剂。 | ||||
| GC73744 | JAB-2485 | 2899209-55-1 | >98.00% | |
JAB-2485是一种有效的选择性极光激酶a (AURKA)抑制剂,IC50为0.33 nM。 | ||||
| GC73760 | Trilexium | 1983180-82-0 | >99.00% | |
Trilexium (TRX-E-009-1)是与TRX-E-002-1结构相关的第三代苯并吡喃。 | ||||
| GC73767 | PKM2-IN-6 | 771467-00-6 | >98.00% | |
PKM2-IN-6(化合物7d)是一种强效的口服活性PKM2抑制剂,IC50值为23nM。 | ||||
| GC73773 | PLK1/BRD4-IN-5 | - | >99.00% | |
PLK1/BRD4-IN-5(化合物SC10)是一种口服活性PLK1和BRD4抑制剂,IC50值分别为0.3 nM和60.8 nM。 | ||||
| GC73774 | YCH2823 | - | >99.00% | |
YCH2823是USP7的抑制剂(IC50 = 49.6 nM;Kd = 0.117 μM)。 | ||||
| GC73795 | T-1-PMPA | 1323883-62-0 | >99.00% | |
T-1-PMPA是一种具有凋亡特性的强效EGFR抑制剂。 | ||||
| GC73808 | Glutor | 2561471-22-3 | >99.00% | |
Glutor是一种选择性GLUT 1/2/3抑制剂,可以抑制葡萄糖摄取。 | ||||
| GC73813 | IOX5 | - | >99.00% | |
IOX5是一种选择性脯氨酸羟化酶(PHD)抑制剂。 | ||||
| GC73822 | GNE-900 | 1200126-26-6 | >99.00% | |
GNE-900是一种ATP竞争性、选择性和口服活性的ChK1抑制剂,ChKl和ChK2的IC50分别为0.0011和1.5µM。 | ||||
| GC73868 | WD6305 TFA | - | >98.00% | |
WD6305 TFA是一种有效的mettl3靶向PROTAC降解剂。 | ||||
| GC73881 | PRO-6E | 2353493-69-1 | >99.00% | |
PRO-6E是一种基于小脑配体的口服活性PROTAC,在MKN-45细胞中,在1 μM时可诱导MET降解,最大降解率为81.9%。 | ||||
| GC73893 | BLU-222 | 2888704-84-3 | >98.00% | |
BLU-222是一种口服活性高选择性CDK2抑制剂。 | ||||
| GC73900 | HA-9104 | 2412367-83-8 | >98.00% | |
HA-9104是一种有效的选择性抑制剂,通过几乎靶向UBE2F的V30口袋来抑制cullin-5 nedylation。 | ||||
| GC73925 | YSR734 | 3032969-58-4 | >98.00% | |
YSR734(化合物21)是一种共价HDAC抑制剂,对HDAC1、HDAC2和HDAC3的IC50值分别为110 nM、154 nM和143 nM。 | ||||
| GC73928 | BDM19 | 500273-31-4 | >98.00% | |
BDM19并单独或与BCL-2/BCL-XL抑制剂Navitoclax联合诱导细胞凋亡。 | ||||
| GC73932 | WK369 | - | >99.00% | |
WK369是一种新型的BCL6小分子抑制剂,具有良好的抗卵巢癌生物活性,可诱导细胞周期阻滞和细胞凋亡。 | ||||
| GC73939 | ATPase-IN-3 | 1134203-12-5 | >99.00% | |
ATPase-IN-3(化合物6)是一种atp酶抑制剂。 | ||||
| GC73940 | BFC1108 | 692774-37-1 | >98.00% | |
BFC1108是一种小分子Bcl-2功能转换器。 | ||||
| GC73943 | Polθ/PARP-IN-1 | - | >99.00% | |
Polθ/PARP-IN-1(化合物25d)是一种有效的双DNA聚合酶θ (Polθ)和PARP抑制剂,IC50值分别为45.6和5.4 nM。 | ||||
| GC73950 | SC912 | - | >99.00% | |
SC912是AR-V7抑制剂(IC50 = 0.36 μM)。 | ||||
| GC73973 | MY-1442 | 3050871-87-6 | >99.00% | |
MY-1442(I-3)是微管蛋白聚合抑制剂。 | ||||
| GC73980 | GGTI-2417 | 501010-05-5 | >98.00% | |
GGTI-2417是GGTase I的强效选择性抑制剂。 | ||||
